Wanchen Biotechnology released its performance for the first half of the year, with a net profit attributable to the parent company of 472 million yuan, an increase of 50,358.8%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Wanchen Biotechnology released its semi-annual report for 2025, showing an operating income of 22.583 billion yuan, a year-on-year increase of 106.89%. The net profit attributable to shareholders of the listed company was 472 million yuan, a year-on-year increase of 50,358.80%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 451 million yuan. The basic earnings per share were 2.62 yuan
According to the Zhitong Finance APP, Wanchen Biotechnology (300972.SZ) released its semi-annual report for 2025, showing an operating income of 22.583 billion yuan, a year-on-year increase of 106.89%. The net profit attributable to shareholders of the listed company was 472 million yuan, a year-on-year increase of 50,358.80%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 451 million yuan. The basic earnings per share were 2.62 yuan